Location History:
- Brookline, MA (US) (2006 - 2008)
- Ann Arbor, MI (US) (2011 - 2018)
Company Filing History:
6 out of 1,209 
1 out of 3,378 
1 out of 2,009 
Years Active: 2006-2018
Title: The Innovative Contributions of Jiandie Lin
Introduction
Jiandie Lin, an esteemed inventor based in Ann Arbor, Michigan, has made significant strides in the field of metabolic and lipid disorders through his patented inventions. With a total of seven patents, Lin has contributed to advancements that aim to improve the health and quality of life for individuals affected by these conditions.
Latest Patents
Among Jiandie Lin's most notable recent patents are several innovative methods targeting metabolic disorders. One of his inventions outlines methods for treating metabolic and/or lipid disorders by administering a therapeutically effective amount of Nrg4, an Nrg4 variant, or a biologically active fragment thereof. Additionally, he has developed compositions and methods for modulating PGC-1β, targeting lipid-related diseases such as hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, cardiovascular disease, obesity, and type II diabetes. This patent also details methods for identifying compounds capable of treating or preventing these lipid-related diseases or disorders.
Career Highlights
Throughout his career, Jiandie Lin has been associated with prestigious organizations, including the Dana-Farber Cancer Institute and the University of Michigan. His research and innovations reflect a deep commitment to addressing complex biological and medical challenges, particularly in the realm of lipid metabolism and its related disorders.
Collaborations
Jiandie Lin has collaborated with prominent figures in the scientific community, including Bruce M. Spiegelman and Guoxiao Wang. These partnerships have likely fostered a rich environment for innovation, leading to the development of impactful strategies in the treatment of metabolic disorders.
Conclusion
Jiandie Lin stands out as a dedicated inventor whose work in the field of metabolic and lipid disorders demonstrates the potential for scientific innovation to enhance patient care and treatment options. His patented methods and ongoing research signify a promising future in the fight against such critical health issues.